Franklin Biotechnology Discv Z(acc)GBP (FUND:B76CRG3) - Fund price


Fund Report

Franklin Biotechnology Discovery Fund Z(acc)GBP

Key Stats
Morningstar® CategorySector Equity Biotechnology
Manager NameEvan McCulloch
Inception Date04/05/2012
NAV 20/09/2019GBP 32.07
Day Change0.75%
12 Month Yield0.00%
ISINLU0774687577
Dividend Frequency-
Net Assets (mil) 31/08/20191,695.91 USD
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time15:00:00
Regular InvestmentYes
Actual Initial Charge0.00%
Exit Charge0.00%
Custody ChargeYes
Ongoing Cost1.32%
AMC1.00%
Fund Rebate0.05%

Morningstar Rating™

StarRatingValueLabel_3

Morningstar Sustainability Rating

Below Average

Below Average


Sustainability Rating as of 31/07/2019

Benchmarks

Fund Benchmark

NASDAQ Biotechnology PR USD

Morningstar® Benchmark

NASDAQ Biotechnology TR USD

Morningstar Analyst Rating™ *

Neutral

Growth Of 10,000 (GBP) 31/08/2019

How has this security performed
201420152016201720182019
Fund43.8011.55-1.247.20-10.9217.17
Category38.5413.41-3.9610.29-7.9613.04
Benchmark42.7618.24-6.1811.10-3.2011.53
  • Fund: Franklin Biotechnology Discovery Fund Z(acc)GBP
  • Category: Sector Equity Biotechnology
  • Benchmark: NASDAQ Biotechnology TR USD
Trailing Returns % (GBP) 20/09/2019
FundCatBmark
YTD17.3913.2811.35
3 Years Annualised2.824.194.06
5 Years Annualised7.257.968.94
10 Years Annualised---

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.

Portfolio Profile31/08/2019

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
IncreaseAmgen Inc Healthcare7.56
IncreaseVertex Pharmaceuticals Inc Healthcare6.18
IncreaseAlexion Pharmaceuticals Inc Healthcare5.57
IncreaseGilead Sciences Inc Healthcare5.13
Illumina Inc Healthcare4.36
Asset Allocation %
LongShortNet
Stocks93.670.0093.67
Bonds0.000.000.00
Cash5.790.005.79
Other0.540.000.54
Top Stock Regions
Region%
United States91.48
United Kingdom4.09
Eurozone2.72
Canada0.96
Europe - ex Euro0.75
Top Stock Sectors
Stock Sector%
Healthcare100.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.